Drs. Jeremy Shefner (Barrow Neurological Institute) and Christopher Coffey (University of Iowa) will discuss how ALS drugs are brought through the pipeline, clinical trial design and issues to consider when interpreting the results of small trials.
Drs. Jeremy Shefner (Barrow Neurological Institute) and Christopher Coffey (University of Iowa) will discuss how ALS drugs are brought through the pipeline, clinical trial design and issues to consider when interpreting the results of small trials.